Insulin activates the PI3K-Akt survival pathway in vulnerable neurons following global brain ischemia

Neurol Res. 2009 Nov;31(9):947-58. doi: 10.1179/174313209X382449. Epub 2009 Feb 6.

Abstract

Insulin is neuroprotective following transient global brain ischemia; however, the mechanisms by which insulin exerts its salutary effects remain unclear.

Objective: We assessed insulin's effect on the PI3K-Akt survival system and consequent modulation of the pro-apoptotic proteins Bim, Bad and FoxO3a.

Methods: We utilized rats subjected to 10 minutes of global brain ischemia, with or without insulin administered at the onset of reperfusion.

Results: In sham-operated animals, minimal pAkt immunofluorescence was detected in the CA1. Moreover, at 30 minute reperfusion, there was no change in pAkt in CA1 neurons. Single bolus high-dose insulin treatment resulted in an early increase in pAkt after 30 minutes, preservation of CA1 neurons to 14 days of reperfusion and preservation of spatial learning ability. Insulin treatment increased cytoplasmic and nuclear staining for pAkt in both CA1 and cortex. Insulin-induced Akt phosphorylation was suppressed by the PI3K inhibitor wortmannin. Neither reperfusion nor insulin induced any change in the phosphorylation or subcellular localization of FoxO3a, Bim or Bad. A single bolus of high-dose insulin reduced CA1 neuronal cell death and thus represents a potential therapeutic intervention for global brain ischemia.

Discussion: These results reveal that proximal elements of a known cell-survival pathway are triggered by high-dose insulin during early reperfusion. Insulin induces robust PI3K-dependent phosphorylation of Akt by 30 minute reperfusion and results in improvement of hippocampal structure and function. However, the Akt substrates FoxO3a, Bim and Bad do not undergo corresponding changes in phosphorylation or subcellular localization in this model of global brain ischemia. The downstream components of insulin-induced Akt survival signaling after transient global brain ischemia remain to be identified.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis Regulatory Proteins / drug effects
  • Apoptosis Regulatory Proteins / metabolism
  • Bcl-2-Like Protein 11
  • Brain Ischemia / drug therapy*
  • Brain Ischemia / enzymology
  • Brain Ischemia / physiopathology
  • CA1 Region, Hippocampal / drug effects
  • CA1 Region, Hippocampal / enzymology
  • CA1 Region, Hippocampal / physiopathology
  • Cell Survival / drug effects
  • Cell Survival / physiology
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Forkhead Box Protein O3
  • Forkhead Transcription Factors / drug effects
  • Forkhead Transcription Factors / metabolism
  • Insulin / metabolism
  • Insulin / pharmacology*
  • Insulin / therapeutic use
  • Male
  • Membrane Proteins / drug effects
  • Membrane Proteins / metabolism
  • Memory Disorders / drug therapy
  • Memory Disorders / enzymology
  • Memory Disorders / physiopathology
  • Neurons / drug effects*
  • Neurons / enzymology
  • Neuroprotective Agents / metabolism
  • Neuroprotective Agents / pharmacology*
  • Neuroprotective Agents / therapeutic use
  • Phosphatidylinositol 3-Kinases / drug effects*
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphorylation / drug effects
  • Proto-Oncogene Proteins / drug effects
  • Proto-Oncogene Proteins / metabolism
  • Proto-Oncogene Proteins c-akt / drug effects*
  • Proto-Oncogene Proteins c-akt / metabolism
  • Rats
  • Rats, Long-Evans
  • Reperfusion Injury / drug therapy
  • Reperfusion Injury / enzymology
  • Reperfusion Injury / physiopathology
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • bcl-Associated Death Protein / drug effects
  • bcl-Associated Death Protein / metabolism

Substances

  • Apoptosis Regulatory Proteins
  • Bad protein, rat
  • Bcl-2-Like Protein 11
  • Bcl2l11 protein, rat
  • FOXO3 protein, rat
  • Forkhead Box Protein O3
  • Forkhead Transcription Factors
  • Insulin
  • Membrane Proteins
  • Neuroprotective Agents
  • Proto-Oncogene Proteins
  • bcl-Associated Death Protein
  • Proto-Oncogene Proteins c-akt